Skip to content

Advertisement

Journal for ImmunoTherapy of Cancer

What do you think about BMC? Take part in

Open Access

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

  • Sotirios P. Fortis1,
  • Michael Sofopoulos2,
  • Nectaria N. Sotiriadou2,
  • Christoforos Haritos1,
  • Christoforos K. Vaxevanis1,
  • Eleftheria A. Anastasopoulou1,
  • Nicole Janssen3,
  • Niki Arnogiannaki2,
  • Alexandros Ardavanis4,
  • Graham Pawelec3,
  • Sonia A. Perez1Email author and
  • Constantin N. Baxevanis1
Contributed equally
Journal for ImmunoTherapy of Cancer20175:48

https://doi.org/10.1186/s40425-017-0248-z

Received: 15 May 2017

Accepted: 15 May 2017

Published: 30 May 2017

The original article was published in Journal for ImmunoTherapy of Cancer 2017 5:39

Erratum

After publication of this article [1], it was noticed that Table 3 contained errors introduced during the production process. The corrected Table 3 can be seen below and the original article has been updated to correct the errors.
Table 3

Multivariate Cox proportional hazard analysis for DFS and OS of patients with non-mesastatic invasive breast cancer

 

DFS

OS

Hazard Ratio

P

95.0% CI for HR (range)

Hazard Ratio

P

95.0% CI for HR (range)

 TNM stageb

2.180

0.009

1.219–3.898

3.937

0.006

1.494–10.371

 Signaturesb

1.560

0.138

0.866–2.810

2.085

0.091

0.889–4.890

Model before stepwise selection

 Agea

1.031

0.948

0.411–2.589

4.391

0.188

0.486–39.703

 T statusb

2.613

0.010

1.255–5.439

3.679

0.028

1.148–11.793

 N stageb

1.222

0.512

0.671–2.225

1.125

0.815

0.420–3.010

 Gradeb

1.142

0.750

0.504–2.585

4.189

0.027

1.180–14.867

 HER-2/neu

0.928

0.884

0.342–2.520

0.066

0.016

0.007–0.066

 Hormone Receptors

0.277

0.004

0.277–0.669

0.618

0.007

0.046–0.621

 Signaturesb

2.063

0.041

1.031–4.126

4.850

0.014

1.374–17.122

Model after stepwise selection

 T statusb

2.999

0.001

1.602–5.615

3.522

0.005

1.477–8.398

 Hormone Receptors

0.269

0.002

0.116–0.621

0.231

0.014

0.072–0.742

 Signaturesb

2.146

0.027

1.091–4.219

4.273

0.006

1.521–11.999

aAge under 50 and over 50 years old

bAll categorical covariates were transformed into numeric codes as follows: T status (T1; 1, T2; 2, T3; 3), N stage (NO; 0, N1; 1, N2; 2, N3; 3), Grade (G1; 1, G2; 2, G3; 3), Signatures (FCIS; 1, Rest; 2, UCIS; 3) TNM stage (I; 1, II; 2, III; 3)

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital
(2)
Pathology Department, Saint Savas Cancer Hospital
(3)
Center for Medical Research, Eberhard-Karls Universität
(4)
First Medical Oncology Clinic, Saint Savas Cancer Hospital

Reference

  1. Fortis, S. P., Sofopoulos, M., Sotiriadou, N. N., Haritos, C., Vaxevanis, C. K., Anastasopoulou, E. A., … Baxevanis, C. N. Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer. J Immunother Cancer. 2017, 5, 39. http://doi.org/10.1186/s40425-017-0240-7.Google Scholar

Copyright

© The Author(s). 2017

Advertisement